Skip to main content
. 2016 Nov 18;11(11):e0166840. doi: 10.1371/journal.pone.0166840

Table 1. Patients characteristics.

Variables Subjects (n = 17)
Age (years), median, IQR* 71, 66–80
Gender (Male / Female) 14 / 3
Body mass index (kg/m2), median, IQR* 22.0, 20.8–22.8
Comorbidities
    Smoking history, number, percentage 12, 70.6%
    Hypertension, number, percentage 14, 82.4%
    Dyslipidemia, number, percentage 12, 70.6%
    Coronary artery disease, number, percentage 3, 17.6%
    Cerebrovascular disease, number, percentage 5, 29.4%
    Diabetes mellitus, number, percentage 12, 70.6%
Medications
    Ca-blocker, number, percentage 10, 58.8%
    β-blocker, number, percentage 3, 17.6%
Hemodynamical parameters
    Ankle brachial pressure index, median, IQR* 0.82, 0.63–0.98
    Reactive hyperemia index, median, IQR* 1.46, 1.36–1.68
Laboratory findings
    White blood cell (/μl), median, IQR* 6400, 5700–7300
    Hemoglobin (g/dl), median, IQR* 12.8, 12.2–14.7
    Platelet (x104/μl), median, IQR* 21.6, 18.9–25.2
    Prothrombin time (%), median, IQR* 101.8, 91.7–107.3
    Activated partial thromboplastin time (sec), median, IQR* 28.4, 27–30.1
    Fibrinogen (mg/dl), median, IQR* 304, 269–317
    D-Dimer (μg/ml), median, IQR* 1.06, 0.78–2.10
    Creatinine (mg/dl), median, IQR* 0.92, 0.78–1.44
    Total cholesterol (mg/dl), median, IQR* 193, 160–205
    Triglycerides (mg/dl), median, IQR* 92, 71–205
    High-density lipoprotein (mg/dl), median, IQR* 54, 48–67
    Low-density lipoprotein (mg/dl), median, IQR* 116, 101–121
    Hemoglobin A1c (%), median, IQR* 6.75, 6.45–7.05
    C-reactive protein (mg/dl), median, IQR* 0.08, 0.05–0.17
    Thrombomodulin (FU/ml) 18.5, 13.7–21.3

* IQR, interquartile range.